Skip to main content

Advertisement

SpringerLink
Log in

Chemokine control of HIV-1 infection

  • Scientific Correspondence
  • Published:

From Nature

View current issue Submit your manuscript

Abstract

Chemokines are proinflammatory cytokines that attract and activate specific types of leukocyte1. There are two main chemokine families, based on the position of the first two cysteine residues: the CC and the CXC chemokines1. Chemokines mediate their effects through interactions with seven-transmembrane-spanning glyco-protein receptors coupled to a G-protein signalling pathway1. Chemokine receptors normally undergo a ligand-mediated homodimerization process, which is required for Ca2+ flux and chemotaxis2. Here we show that in the chemokine response it is possible for heterodimerization, rather than homodimerization, to occur between a mutant form of the CCR2 receptor (the CCR2V64I receptor), which helps to delay the development of AIDS in HIV-1-infected individuals, and the CCR5 or CXCR4 chemokine receptor, which are used by HIV to gain entry into cells. These results may explain why AIDS takes longer to develop in HIV-1-infected individuals carrying the CCR2V64I mutation3.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1: Ability of the mutant CCR2V64I receptor to form heterodimers with the CXCR4 receptor.

References

  1. Baggiolini, M. Nature 392, 565–568 (1998).

    Article  ADS  CAS  Google Scholar 

  2. Rodríguez-Frade, J. M. et al. Proc. Natl. Acad. Sci. USA 96, 3628–3633 (1999).

    Google Scholar 

  3. Smith, M. W. et al. Science 277, 959–965 (1997).

    Google Scholar 

  4. Berger, E. A., Murphy, P. M. & Farber, J. M. Annu. Rev. Immunol. 17, 657–700 (1999).

    Google Scholar 

  5. Cairns, J. S. & D'souza, M. P. Nature Med. 4, 563–568 (1998).

    Google Scholar 

  6. Rucker, J. et al. Cell 87, 437–446 (1996).

    Google Scholar 

  7. White, J. H. et al. Nature 396, 679–682 (1998).

    Article  ADS  CAS  PubMed  Google Scholar 

  8. Vila-Coro, A. J. et al. (in the press).

  9. Rodríguez-Frade, J. M. et al. J. Cell Biol. 144, 755–765 (1999).

    Google Scholar 

  10. Rodríguez-Frade, J. M. et al. J. Clin. Invest. 100, 497 (1997).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Immunology and Oncology, Centro Nacional de Biotecnología/CSIC, Universidad Autónoma de Madrid, Campus de Cantoblanco, 28049, Madrid, Spain

    Mario Mellado, José Miguel Rodríguez-Frade, Antonio J. Vila-Coro, Ana Martín de Ana & Carlos Martínez-A.

Authors
  1. Mario Mellado
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. José Miguel Rodríguez-Frade
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio J. Vila-Coro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Ana Martín de Ana
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Carlos Martínez-A.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mellado, M., Rodríguez-Frade, J., Vila-Coro, A. et al. Chemokine control of HIV-1 infection. Nature 400, 723–724 (1999). https://doi.org/10.1038/23382

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/23382

  • Springer Nature Limited

This article is cited by

Search

Navigation